Isracann Biosciences Inc.

ISCNF · OTC
Analyze with AI
8/31/2022
5/31/2022
2/28/2022
11/30/2021
Operating Activities
Net Income-$316-$2,730-$620-$874
Dep. & Amort.$10$10$10$10
Deferred Tax$0$0$0$0
Stock-Based Comp.$4$5$7$43
Change in WC$129$309$52$279
Other Non-Cash$10$2,190$29-$33
Operating Cash Flow-$163-$215-$522-$575
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$39$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$39$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$104$130$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$47$130$0$0
Financing Cash Flow$152$130$0$0
Forex Effect-$4-$51$6$3
Net Chg. in Cash-$16-$97-$516-$572
Supplemental Information
Beg. Cash$214$311$827$1,399
End Cash$198$214$311$827
Free Cash Flow-$163-$215-$522-$575
Isracann Biosciences Inc. (ISCNF) Financial Statements & Key Stats | AlphaPilot